北大医药
(000788)
| 流通市值：32.06亿 | | | 总市值：32.06亿 |
| 流通股本：5.96亿 | | | 总股本：5.96亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 447,110,790.57 | 215,174,005.41 | 1,482,371,745.21 | 1,231,193,296.53 |
| 营业收入 | 447,110,790.57 | 215,174,005.41 | 1,482,371,745.21 | 1,231,193,296.53 |
| 二、营业总成本 | 376,536,216.85 | 187,513,185.93 | 1,324,838,103.56 | 1,079,788,503.83 |
| 营业成本 | 287,793,031.18 | 142,377,161.01 | 1,066,813,617.67 | 898,422,808.9 |
| 税金及附加 | 3,646,293.77 | 1,677,550.74 | 8,839,884.97 | 6,968,199.74 |
| 销售费用 | 34,154,799.97 | 16,976,227.13 | 115,907,882.26 | 85,094,415.36 |
| 管理费用 | 44,259,929.48 | 22,917,212.77 | 109,539,749.88 | 72,871,243.87 |
| 研发费用 | 9,963,009.85 | 4,836,976.91 | 26,855,927.91 | 18,323,173.01 |
| 财务费用 | -3,280,847.4 | -1,271,942.63 | -3,118,959.13 | -1,891,337.05 |
| 其中:利息费用 | 1,047,111.86 | 604,169.44 | 2,379,112.33 | 1,937,103.3 |
| 其中:利息收入 | 4,409,132.1 | 1,938,026.78 | 5,641,373.11 | 3,945,999.19 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 40,445.07 | 197,532.22 | - | 6,376,117.2 |
| 加:投资收益 | 14,363,271.73 | 1,989,086.49 | 6,891,785.09 | 2,471,927.03 |
| 资产处置收益 | -24,269.75 | -24,269.75 | 29,633.81 | -45,302.3 |
| 资产减值损失(新) | -20,063,535.94 | - | -37,476,062.15 | -51,160.27 |
| 信用减值损失(新) | -117,124.99 | 184,380.23 | 11,026,265.48 | 728,036.56 |
| 其他收益 | 2,047,252.59 | 1,247,255.06 | 3,857,734.76 | 3,153,441.29 |
| 四、营业利润 | 66,820,612.43 | 31,254,803.73 | 141,862,998.64 | 164,037,852.21 |
| 加:营业外收入 | 348,557.41 | 80,366.13 | 5,044,386.43 | 3,680,341.96 |
| 减:营业外支出 | 68,708.16 | 24,383.02 | 44,241,248.56 | 1,062,531.12 |
| 五、利润总额 | 67,100,461.68 | 31,310,786.84 | 102,666,136.51 | 166,655,663.05 |
| 减:所得税费用 | 11,429,647.93 | 4,314,496.93 | 19,783,178.72 | 30,675,009.9 |
| 六、净利润 | 55,670,813.75 | 26,996,289.91 | 82,882,957.79 | 135,980,653.15 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 55,670,813.75 | 26,996,289.91 | 82,882,957.79 | 135,980,653.15 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 55,670,813.75 | 26,996,289.91 | 82,882,957.79 | 135,980,653.15 |
| 扣除非经常损益后的净利润 | 43,323,842.59 | 26,495,493.05 | 100,844,196.13 | 126,104,150.33 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.09 | 0.05 | 0.14 | 0.23 |
| (二)稀释每股收益 | 0.09 | 0.05 | 0.14 | 0.23 |
| 九、综合收益总额 | 55,670,813.75 | 26,996,289.91 | 82,882,957.79 | 135,980,653.15 |
| 归属于母公司股东的综合收益总额 | 55,670,813.75 | 26,996,289.91 | 82,882,957.79 | 135,980,653.15 |
| 公告日期 | 2026-08-25 | 2026-04-28 | 2026-04-28 | 2025-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |